Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Cardiff Oncology, Inc. (CRDF) had Operating Cash Flow per Share of $-0.19 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.11M |
|
$-13.44M |
|
-- |
|
$0.11M |
|
$14.49M |
|
$-14.38M |
|
$0.95M |
|
$-13.43M |
|
$-13.43M |
|
$-13.43M |
|
$-13.43M |
|
$-13.43M |
|
$-13.43M |
|
$-14.38M |
|
$-14.43M |
|
66.52M |
|
66.52M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$82.71M |
|
$0.81M |
|
$2.10M |
|
$84.81M |
|
$13.29M |
|
-- |
|
$0.64M |
|
$13.93M |
|
$70.88M |
|
$70.88M |
|
$70.88M |
|
66.53M |
|
| Cash Flow Statement Financials | |
$-12.79M |
|
$-14.58M |
|
$0.00M |
|
$51.47M |
|
$24.09M |
|
$-27.38M |
|
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-13194.50% |
|
-13194.50% |
|
-- |
|
-12324.77% |
|
-12330.28% |
|
$-12.79M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.27 |
|
334.40 |
|
-18.95% |
|
-18.95% |
|
-15.84% |
|
-18.95% |
|
$1.07 |
|
$-0.19 |
|
|
Operating Cash Flow per Share |
$-0.19 |